FAM174B and Familial prostate cancer: Notably, in prostate cancer, elevated FAM174B expression correlates with high KLK2 levels but predicts poorer responses to immune checkpoint inhibitors, hinting at a complex immunomodulatory function that warrants further investigation 21.